Generalized Myositis in Behcet Disease:TReatment with Cyclosporine
Ann Int Med 116:651-653, Lingenfelser,T.,et al, 1992
Behcet's Disease
NEJM 341:1284-1291, Sakane,T.,et al, 1999
Treatment of Inflammatory Myopathies
Muscle & Nerve 20:651-664997., Mastaglia,F.L.,et al, 1997
Cyclosporine-Associated Mutism in Liver Transplant Patients
Neurol 46:252-254, Valldeoriola,F.,et al, 1996
Neurotoxicity in Liver Transplant Recipients with Cyclosporine Immunosuppression
Neurol 45:1962-1964, Wijdicks,E.F.M.,et al, 1995
Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994
Neurological Complications Following Liver Transplantation
Ann Neurol 31:644-649, Stein,D.P.,et al, 1992
Cyclosporin in the Management of Polymyositis and Dermatomyositis
JNNP 54:1007-1008, Lueck,C.J.,et al, 1991
Cyclosporine-Related Central Nervous System Toxicity in Cardiac Transplantation
NEJM 323:420-421, Hughes,R.L., 1990
A Double-Blind Study of the Effectiveness of Cyclosporine in Amyotrophic Lateral Sclerosis
Arch Neurol 45:381-386, Appel,S.H.,et al, 1988
Cerebral Blindness & Encephalopathy with Cyclosporin A Toxicity
Neurol 37:1072-1076, Rubin,A.M.&Kang,H., 1987
Central Nervous System Toxicity After Liver Transplantation, The Role of Cyclosporine & Cholesterol
NEJM 317:861-866, DeGroen,P.C.,et al, 1987
Cyclosporine-Associated Central-Nervous-System Toxicity after Allogeneic Bone-Marrow Transplantation
NEJM 310:527, Atkinson,K.,et al, 1984